Compugen Ltd
NASDAQ:CGEN
Compugen Ltd
Cash from Operating Activities
Compugen Ltd
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Compugen Ltd
NASDAQ:CGEN
|
Cash from Operating Activities
$-32.5m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
-18%
|
|
Q
|
Quoin Pharmaceuticals Ltd
NASDAQ:QNRX
|
Cash from Operating Activities
$-7.9m
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
B
|
Biolight Life Sciences Ltd
TASE:BOLT
|
Cash from Operating Activities
₪-9.6m
|
CAGR 3-Years
6%
|
CAGR 5-Years
16%
|
CAGR 10-Years
10%
|
See Also
What is Compugen Ltd's Cash from Operating Activities?
Cash from Operating Activities
-32.5m
USD
Based on the financial report for Dec 31, 2023, Compugen Ltd's Cash from Operating Activities amounts to -32.5m USD.
What is Compugen Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
-18%
Over the last year, the Cash from Operating Activities growth was 6%. The average annual Cash from Operating Activities growth rates for Compugen Ltd have been -5% over the past three years , -20% over the past five years , and -18% over the past ten years .